Zeba Hashmath
Internal Medicine · Worcester, MANPI 1700309622
Payments from drug & device makers
Across 366 payments — averaging $131.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$19K
- Biotronik Inc.$10K
- Boston Scientific$8K
- Medtronic$7K
- Biosense Webster, Inc.$614
- Cvrx, Inc.$589
- plus $3K from 26 others
What the payments were for
- Grants$16,93835%
- Travel & lodging$14,14129%
- Food & beverage$15,70033%
- Education$1,3973%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 78 | $19,182 |
| Biotronik Inc. | 68 | $9,529 |
| Boston Scientific | 23 | $7,919 |
| Medtronic | 61 | $6,951 |
| Biosense Webster, Inc. | 8 | $614 |
| Cvrx, Inc. | 12 | $589 |
| AstraZeneca(2 entities) | 22 | $544 |
| Abiomed | 6 | $485 |
| Novartis | 18 | $420 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $384 |
| Johnson & Johnson | 13 | $360 |
| Boehringer Ingelheim | 5 | $182 |
| Irhythm Technologies, Inc. | 3 | $154 |
| Baxter Healthcare | 1 | $149 |
| Amgen | 5 | $100 |
| Pfizer | 5 | $75 |
| Biogen | 3 | $74 |
| Alnylam Pharmaceuticals Inc. | 3 | $56 |
| Impulse Dynamics (USA) Inc. | 1 | $53 |
| AbbVie | 2 | $47 |
| Terumo Medical Corporation | 2 | $43 |
| Shire North American Group Inc | 2 | $40 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Cardiva Medical, Inc. | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Novo Nordisk | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL BRADY$3,750
- ASSURITY$2,813
- ENSITE$2,666
- TACTICATH$2,250
- ENSITE PRECISION$1,850
- GALLANT$1,353
- Acticor 7 VR-T DX$1,268
- Edora 8 DR-T$1,139
- BioMonitor$1,026
- Rivacor 7 DR-T$624
- WATCHMAN Access System$595
- Carto 3$396
- Impella$388
- Solia$348
- Plexa ProMRI$347
- Barostim Neo System$268
- EnSite Precision Cardiac Mapping System$209
- AVEIR$152
- Hillrom - Cardiac Ambulatory Monitor$149
- JARDIANCE$125
How this compares
$48,175 in reported general payments places this provider in the 95th percentile of 4,983 internal medicine providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 74 | $58,654 |
| EliquisApixaban | 38 | $27,667 |
| JardianceEmpagliflozin | 18 | $14,980 |
| Repatha SureclickEvolocumab | 14 | $7,821 |
| Ranolazine ErRanolazine | 12 | $1,235 |
| Valsartan | 21 | $639 |
| Metoprolol Succinate | 52 | $547 |
| SotalolSotalol Hcl | 11 | $416 |
| Ezetimibe | 34 | $395 |
| Atorvastatin Calcium | 21 | $341 |
| Torsemide | 14 | $291 |
| Furosemide | 46 | $214 |
| Rosuvastatin Calcium | 13 | $180 |
| ClopidogrelClopidogrel Bisulfate | 38 | $153 |
| Spironolactone | 24 | $141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $420 | $58,65474 claims |
| PfizerEliquis | $75 | $27,66738 claims |
| Boehringer IngelheimJardiance | $182 | $14,98018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,983 internal medicine providers in Massachusetts.
Other internal medicine in Worcester
- Deepa JagadeeshWorcester$5.6M
- Jee BangWorcester$2.8M
- Noopur RajeBoston$19.9M
- Michael McCartneyNewburyport$17.6M
- Rebecca HeistBoston$17.4M
- Richard PlattBoston$13.5M
- Ryan CorcoranBoston$11.4M
- Joyce LiuCharlestown$10.3M
- Elizabeth LeeBoston$9.8M
- Adnan DahdulSpringfield$8.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.